Franklin Templeton Investments Corp. announced Friday that unitholders have voted in favour of merging Franklin World Health Sciences and Biotech Fund, Franklin World Health Sciences and Biotech Corporate Class and Franklin Technology Corporate Class into Franklin Flex Cap Growth Corporate Class. The merger will take effect as of the close of business on August 24, 2007.

Managed by Conrad Hermann, the $8.23 million Franklin Flex Cap Growth Corporate Class seeks capital appreciation by investing primarily in U.S. equities demonstrating accelerating growth, increasing profitability or above-average growth, or growth potential compared to the overall economy.

The Franklin Flex Cap Growth Corporate Class offers a tax-efficient option for Canadians investing outside of their registered accounts. This fund is part of Franklin Templeton’s Corporate Class structure, which allows investors to switch between funds and portfolios while deferring capital gains until they redeem from the structure.